Garuda Therapeutics Appoints Giorgia Scapin, Ph.D., As Chief Scientific Officer | Citybiz
07/12/23, 6:00 PM
Location
cambridge
Industry
biotechnology
science and engineering
health care
Position
chief scientific officer
CAMBRIDGE, Mass.–– Garuda Therapeutics , a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced the appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer. Transitioning from her previous role as Senior Vice President of Research and Development at Garuda, Dr. Scapin will oversee the company’s scientific strategy and lead the advancement of Garuda’s off-the-shelf hematopoietic stem cell therapies in her new role as Chief Scientific Officer.
Company Info
Location
215 first street
cambridge, massachusetts, united states
Additional Info
Garuda Therapeutics seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible and transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially curative therapies for more than 70 diseases.